重症急性脑损伤患者的肺保护性机械通气:多中心随机临床试验(PROLABI)
本研究为多中心开放标签随机对照试验,纳入190例急性脑损伤成人患者,比较肺保护性通气(低潮气量+适度PEEP)与常规通气的临床结局。结果显示肺保护性策略未改善预后,28天复合终点(死亡、呼吸机依赖、ARDS)在肺保护组为61.5%、常规组为45.3%(RR 1.35,95%CI 1.03-1.79,P=0.025),死亡率分别为28.9%和15.1%(RR 1.91,95%CI 1.06-3.42,P=0.02),因资金终止试验提前结束,结果需更大样本验证。
要点
- 急性脑损伤无ARDS患者中,肺保护性通气未降低死亡、呼吸机依赖或ARDS发生率。
- 肺保护性通气组28天复合终点和死亡率均显著高于常规通气组。
- 试验因资金终止提前结束,初步结果需更大规模试验确认。
核心结论
- 在无ARDS的急性脑损伤患者中,与常规通气相比,肺保护性通气策略未降低死亡率、脱机失败率或ARDS发生率,神经功能结局也无获益。
研究设计与样本
- 多中心、开放标签、随机对照临床试验,纳入190例急性脑损伤成人患者,随机分配至肺保护性通气组或常规通气组,主要终点为28天死亡、呼吸机依赖和ARDS的复合终点。
主要发现
- 28天复合终点在肺保护组为61.5%、常规组为45.3%(RR 1.35,95%CI 1.03-1.79,P=0.025)。
- 死亡率在肺保护组为28.9%、常规组为15.1%(RR 1.91,95%CI 1.06-3.42,P=0.02)。
- 呼吸机依赖率在肺保护组为42.3%、常规组为27.9%(RR 1.52,95%CI 1.01-2.28,P=0.039)。
- ARDS发生率在肺保护组为30.8%、常规组为22.1%(RR 1.39,95%CI 0.85-2.27,P=0.179)。
临床怎么用
- 对于急性脑损伤无ARDS的患者,不宜常规采用肺保护性通气策略(低潮气量+适度PEEP)以改善预后。
局限性
- 试验因资金终止提前结束,纳入样本量有限,结果为初步结论,需更大规模试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Lung-protective strategies using low Vt and moderate positive end-expiratory pressure (PEEP) are considered best practice in critical care, but interventional trials have never been conducted in patients with acute brain injuries because of concerns about carbon dioxide control and the effect of PEEP on cerebral hemodynamics. Objectives: To test the hypothesis that ventilation with lower VT and higher PEEP compared to conventional ventilation would improve clinical outcomes in patients with acute brain injury. Methods: In this multicenter, open-label, controlled clinical trial, 190 adult patients with acute brain injury were assigned to receive either a lung-protective or a conventional ventilatory strategy. The primary outcome was a composite endpoint of death, ventilator dependency, and acute respiratory distress syndrome (ARDS) at Day 28. Neurological outcome was assessed at ICU discharge by the Oxford Handicap Scale and at 6 months by the Glasgow Outcome Scale. Measurements and Main Results: The two study arms had similar characteristics at baseline. In the lung-protective and conventional strategy groups, using an intention-to-treat approach, the composite outcome at 28 days was 61.5% and 45.3% (relative risk [RR], 1.35; 95% confidence interval [CI], 1.03-1.79; P = 0.025). Mortality was 28.9% and 15.1% (RR, 1.91; 95% CI, 1.06-3.42; P = 0.02), ventilator dependency was 42.3% and 27.9% (RR, 1.52; 95% CI, 1.01-2.28; P = 0.039), and incidence of ARDS was 30.8% and 22.1% (RR, 1.39; 95% CI, 0.85-2.27; P = 0.179), respectively. The trial was stopped after enrolling 190 subjects because of termination of funding. Conclusions: In patients with acute brain injury without ARDS, a lung-protective ventilatory strategy, as compared with a conventional strategy, did not reduce mortality, percentage of patients weaned from mechanical ventilation, or incidence of ARDS and was not beneficial in terms of neurological outcomes. Because of the early termination, these preliminary results require confirmation in larger trials. Clinical trial registered with www.clinicaltrials.gov (NCT01690819).
引用
- Mascia L, Fanelli V, Mistretta A, et al. Lung-Protective Mechanical Ventilation in Patients with Severe Acute Brain Injury: A Multicenter Randomized Clinical Trial (PROLABI). Am J Respir Crit Care Med. 2024. PMID: 39288368. doi:10.1164/rccm.202402-0375OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。